Interpharm Holdings, Inc.
IPAH · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $38 | $32 | $27 | $17 |
| Enterprise Value | $39 | $33 | $27 | $18 |
| Revenue | $16 | $18 | $15 | $20 |
| % Growth | -8.5% | 15.2% | -22.8% | – |
| Gross Profit | $2 | $1 | $2 | $6 |
| % Margin | 14% | 6.1% | 14.8% | 32% |
| EBITDA | -$3 | -$5 | -$6 | -$2 |
| % Margin | -18.3% | -29.5% | -42.2% | -8.4% |
| Net Income | -$11 | -$7 | -$10 | -$2 |
| % Margin | -67.2% | -38.9% | -63.2% | -9.3% |
| EPS Diluted | -0.21 | -0.1 | -0.153 | -0.04 |
| % Growth | -110% | 34.8% | -283.2% | – |
| Operating Cash Flow | -$6 | -$3 | -$7 | -$5 |
| Capital Expenditures | -$1 | -$2 | -$3 | -$3 |
| Free Cash Flow | -$7 | -$5 | -$10 | -$7 |